Morgan Stanley

13F Holdings History for Arbutus Biopharma Corp - Common Shares, without par value (ABUS)

Symbol: ABUS on Nasdaq
Investment type: Equity / Common Shares, without par value
Latest Disclosed Ownership: 21.5M shares
Security Ownership: 11.4%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in Arbutus Biopharma Corp Common Shares, without par value (ABUS)

2025-02-03 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 21.5M shares of Arbutus Biopharma Corp Common Shares, without par value (ABUS). This represents 11.4% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Morgan Stanley	11.4%		$67.6M	21.5M			$3.14	13G/A	12/31/2024	3 Feb 2025 15:26:45

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.01%	+0%	$111M	24.5M	+288,229	+1.19%	$4.54	Q3 2025
6/30/2025	0%	+0%	$74.7M	24.2M	+369,994	+1.56%	$3.09	Q2 2025
3/31/2025	0.01%	+0%	$83M	23.8M	+1,205,471		$3.49	Q1 2025
12/31/2024	0.01%	+0%	$73.9M	22.6M	+878,467		$3.27	Q4 2024
9/30/2024	0.01%	+0%	$83.6M	21.7M	+748,183		$3.85	Q3 2024
6/30/2024	0.01%	+0%	$64.8M	21M	+12,129,971	+100%	$3.09	Q2 2024
3/31/2024	0%		$22.8M	8.83M			$2.58	Q1 2024
12/31/2023	0%		$17.5M	6.98M			$2.50	Q4 2023
9/30/2023	0%	+0%	$10.7M	5.26M	+180,834	+3.56%	$2.03	Q3 2023
6/30/2023	0%	+0%	$11.7M	5.08M	+197,689	+4.05%	$2.30	Q2 2023
3/31/2023	0%	+0%	$14.8M	4.88M	+4,640,713	+1918%	$3.03	Q1 2023
12/31/2022	0%	+0%	$564K	242K	+29,902	+14.1%	$2.33	Q4 2022
9/30/2022	0%	0%	$405K	212K	-6,962	-3.18%	$1.91^*	Q3 2022
6/30/2022	0%	+0%	$595K	219K	+21,773	+11%	$2.72^*	Q2 2022
3/31/2022	0%	0%	$587K	197K	-41,681	-17.4%	$2.98	Q1 2022
12/31/2021	0%	+0%	$930K	239K	+17,778	+8.04%	$3.89	Q4 2021
9/30/2021	0%	0%	$950K	221K	-70,685	-24.2%	$4.30	Q3 2021
6/30/2021	0%	0%	$884K	292K	-838,598	-74.2%	$3.03	Q2 2021
3/31/2021	0%	0%	$3.76M	1.13M	-291,897	-20.5%	$3.33	Q1 2021
12/31/2020	0%	0%	$5.05M	1.42M	-1,487,452	-51.1%	$3.55	Q4 2020
9/30/2020	0%	0%	$9.11M	2.91M	-443,821	-13.2%	$3.13	Q3 2020
6/30/2020	0%	+0%	$6.1M	3.35M	+1,306,529	+63.8%	$1.82	Q2 2020
3/31/2020	0%	+0%	$2.07M	2.05M	+175,920	+9.4%	$1.01^*	Q1 2020
12/31/2019	0%	+0%	$5.2M	1.87M	+229,442	+14%	$2.78	Q4 2019
9/30/2019	0%	+0%	$2.5M	1.64M	+31,760	+1.97%	$1.53^*	Q3 2019
6/30/2019	0%	+0%	$3.35M	1.61M	+643,955	+66.7%	$2.08	Q2 2019
3/31/2019	0%	0%	$3.46M	966K	-119,644	-11%	$3.58	Q1 2019
12/31/2018	0%	+0%	$4.16M	1.09M	+60,222	+5.87%	$3.83	Q4 2018
9/30/2018	0%	+0%	$9.69M	1.03M	+289,556	+39.4%	$9.45	Q3 2018
6/30/2018	0%	+0%	$5.37M	736K	+221,801	+43.2%	$7.30	Q2 2018
3/31/2018	0%	0%	$2.57M	514K	-114,681	-18.2%	$5.00	Q1 2018
12/31/2017	0%	+0%	$3.17M	629K	+207,076	+49.1%	$5.05	Q4 2017
9/30/2017	0%	+0%	$2.61M	422K	+94,353	+28.8%	$6.20	Q3 2017
6/30/2017	0%	+0%	$1.18M	327K	+34,553	+11.8%	$3.60	Q2 2017
3/31/2017	0%	+0%	$951K	293K	+14,695	+5.29%	$3.25	Q1 2017
12/31/2016	0%	+0%	$681K	278K	+143,285	+106%	$2.45^*	Q4 2016
9/30/2016	0%	+0%	$464K	135K	+34,862	+34.9%	$3.44	Q3 2016
6/30/2016	0%	+0%	$347K	99.9K	+59,244	+146%	$3.48	Q2 2016
3/31/2016	0%	+0%	$167K	40.6K	+18,591	+84.4%	$4.11	Q1 2016
12/31/2015	0%	0%	$98K	22K	-105,020	-82.7%	$4.45	Q4 2015
9/30/2015	0%	+0%	$774K	127K	+127,038	NEW	$6.09	Q3 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.